SMSLIFE Share Price Performance
₹1,156.30
-273.15 (-19.11%)
Price ₹1,156.30
Share Price₹1,156.30
Here's Why Shareholders May Want To Be Cautious With Increasing Haleos Labs Limited's (NSE:SMSLIFE) CEO Pay Packet
Sep 24
Haleos Labs Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
SMSLIFE Community Narratives
There are no narratives available yet.
Haleos Labs Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 57.27
- Gross Margin
- 36.77%
- Net Profit Margin
- 5.17%
- Debt/Equity Ratio
- 40.7%
Haleos Labs Limited Competitors
Snowflake Analysis
About SMSLIFE
- Founded
- 1990
- Employees
- 592
- CEO
- WebsiteView website
Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products. It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025. Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Indian Market Performance
- 7 Days: 1.8%
- 3 Months: -1.3%
- 1 Year: -2.3%
- Year to Date: 1.1%
Over the last 7 days, the market has risen 1.5%, driven by gains of 2.3% in the Financials sector. Over the past year the market is down 4.7%. Earnings are forecast to grow by 16% annually. Market details ›